Compare · HCA vs MD
HCA vs MD
Side-by-side comparison of HCA Healthcare Inc. (HCA) and Pediatrix Medical Group Inc. (MD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCA and MD operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- HCA is the larger of the two at $92.83B, about 42.3x MD ($2.19B).
- MD has been more active in the news (13 items in the past 4 weeks vs 2 for HCA).
- HCA has more recent analyst coverage (25 ratings vs 10 for MD).
- Company
- HCA Healthcare Inc.
- Pediatrix Medical Group Inc.
- Price
- -
- -
- Market cap
- $92.83B
- $2.19B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2011
- News (4w)
- 2
- 13
- Recent ratings
- 25
- 10
HCA Healthcare Inc.
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Pediatrix Medical Group Inc.
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Latest HCA
- HCA Healthcare, Inc. to Present at September Conferences
- HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
- HCA Healthcare Inc. filed SEC Form 8-K: Other Events, Creation of a Direct Financial Obligation
- SEC Form 10-Q filed by HCA Healthcare Inc.
- HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- HCA Healthcare Reports Second Quarter 2026 Results
- HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call
- HCA Healthcare Previews Second Quarter 2026 Results
- HCA downgraded by Barclays with a new price target
Latest MD
- Pediatrix Medical Group downgraded by Jefferies with a new price target
- Director Young Sylvia Jean returned $492,470 worth of shares to the company (18,500 units at $26.62), decreasing direct ownership by 38% to 29,786 units (SEC Form 4)
- Director Sansone Guy P was granted 472 shares, increasing direct ownership by 0.54% to 87,416 units (SEC Form 4)
- Director Starcher John M. Jr. was granted 472 shares, increasing direct ownership by 0.64% to 73,732 units (SEC Form 4)
- Director Young Sylvia Jean was granted 472 shares, increasing direct ownership by 0.99% to 48,286 units (SEC Form 4)
- Director Rucker Michael A. was granted 472 shares, increasing direct ownership by 0.71% to 66,769 units (SEC Form 4)
- Director Newman Kurt Douglas was granted 472 shares, increasing direct ownership by 3% to 17,405 units (SEC Form 4)
- Director Linynsky Laura A was granted 472 shares, increasing direct ownership by 1% to 39,900 units (SEC Form 4)
- Director Weis Shirley A was granted 472 shares, increasing direct ownership by 3% to 19,095 units (SEC Form 4)
- Director Mceachin Thomas was granted 472 shares, increasing direct ownership by 7% to 7,668 units (SEC Form 4)